News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
824,131 Results
Type
Article (85253)
Company Profile (622)
Press Release (738256)
Section
Business (231829)
Career Advice (4090)
Deals (39621)
Drug Delivery (106)
Drug Development (90416)
Employer Resources (192)
FDA (17878)
Job Trends (17246)
News (394564)
Policy (39583)
Tag
Academia (2973)
Africa (1262)
Alliances (56326)
Alzheimer's disease (1241)
Approvals (17792)
Arizona (209)
Artificial intelligence (85)
Asia (48986)
Australia (8614)
Bankruptcy (392)
Best Places to Work (12244)
Biotechnology (436)
C2C Services and Suppliers (95129)
California (1959)
Canada (926)
Cancer (493)
Career advice (3497)
Cell therapy (140)
China (150)
Clinical research (70368)
Collaboration (147)
Colorado (80)
Compensation (79)
Connecticut (80)
COVID-19 (2753)
Cystic fibrosis (77)
Data (277)
Diabetes (89)
Diagnostics (6495)
Drug pricing (81)
Earnings (93516)
Employer resources (162)
Europe (111964)
Events (124945)
Executive appointments (147)
FDA (18089)
Florida (265)
Funding (144)
Gene therapy (105)
GLP-1 (615)
Government (5004)
Healthcare (20646)
Hotbed/Location (534624)
Illinois (315)
Indiana (159)
Infectious disease (2783)
Inflammatory bowel disease (101)
Interviews (805)
IPO (17482)
Job creations (5172)
Job search strategy (2849)
Kansas (100)
Layoffs (467)
Legal (10011)
Lung cancer (114)
Manufacturing (98)
Maryland (421)
Massachusetts (1674)
Medical device (14257)
Medtech (14262)
Mergers & acquisitions (21950)
Metabolic disorders (291)
Michigan (135)
Minnesota (235)
Neuroscience (1400)
New Jersey (591)
New York (598)
NextGen Class of 2024 (7622)
Non-profit (5052)
North Carolina (695)
Northern California (826)
Obesity (173)
Ohio (110)
Opinion (234)
Patents (74)
Pennsylvania (585)
People (63690)
Pharmaceutical (119)
Phase I (21607)
Phase II (30551)
Phase III (23083)
Pipeline (106)
Podcasts (75)
Postmarket research (3532)
Preclinical (9761)
Press Release (72)
Rare diseases (140)
Real estate (7361)
Recruiting (72)
Regulatory (25582)
Research institute (2633)
Resumes & cover letters (645)
South America (1640)
Southern California (748)
Startups (4271)
Texas (251)
United States (9130)
Vaccines (561)
Washington State (275)
Weight loss (165)
Date
Today (73)
Last 7 days (724)
Last 30 days (2246)
Last 365 days (39987)
2024 (27793)
2023 (42566)
2022 (53929)
2021 (58727)
2020 (57671)
2019 (51341)
2018 (39126)
2017 (37193)
2016 (38330)
2015 (44433)
2014 (39673)
2013 (36269)
2012 (38416)
2011 (38383)
2010 (39616)
There are 824,131 results that match your search.
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PatientSeek identifies a genetic signature that separates a4b7 integrin therapy responder and non-responder populations in inflammatory bowel disease
September 16, 2024
·
3 min read
Press Releases
Certa Therapeutics Announces International Non-Proprietary Name for its First-in-class GPR68 Inhibitor Asengeprast (FT011)
September 16, 2024
·
4 min read
Press Releases
Novartis Kisqali® shows deepening benefit in new analysis, reducing the risk of recurrence by 28.5% in a broad population of patients with early breast cancer
September 16, 2024
·
14 min read
Press Releases
Akeso’s Ivonescimab plus Chemo in First-Line Triple-negative Breast Cancer Showed Promising Preliminary Efficacy and Good Safety at ESMO 2024
September 16, 2024
·
2 min read
Press Releases
Kronos Advanced Technologies, Inc. (OTC: KNOS) Announces Ex-Dividend Date for Upcoming Special Cash Dividend
September 16, 2024
·
8 min read
Press Releases
Penumbra Receives CE Mark for Computer Assisted Vacuum Thrombectomy Technologies - Lightning Flash™ 2.0 and Lightning Bolt™ 7 - in Europe
September 16, 2024
·
7 min read
Press Releases
Adagene Presents Results at ESMO Congress that Show Best-in-Class Therapeutic Potential for Anti-CTLA-4 SAFEbody® ADG126 (Muzastotug) in Combination with KEYTRUDA® (Pembrolizumab) in Advanced/Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)
September 16, 2024
·
10 min read
Press Releases
Neoadjuvant TAR-200 plus cetrelimab nearly doubles the pathological complete response rate compared to cetrelimab alone in patients with muscle invasive bladder cancer
September 16, 2024
·
10 min read
Press Releases
AAVantgarde announces first patient dosed in First-In-Human Phase 1/2 LUCE-1 study, evaluating AAVB-081 (Dual-AAV) in retinitis pigmentosa related to Usher Syndrome type 1B
September 16, 2024
·
4 min read
Press Releases
MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases
September 16, 2024
·
6 min read
1 of 82,414
Next
